Current therapeutic researchPublic disclosure of clinical trials in children
References (47)
- et al.
FDAMA's written request list: Medicines for children
Lancet
(2001) - et al.
Closing the gap in drug therapy
Lancet
(1999) - et al.
A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler
J Allergy Clin Immunol
(1997) - et al.
Randomized trial comparing 5-day cefpodoxime proxetil and 8-day amoxicillin-clavulanate treatment of acute otitis media in children
Med Mal Infect
(1997) - et al.
A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children
J Pediatr
(1998) - et al.
Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through typanostomy tubes
J Pediatr
(1999) - et al.
Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma
Respir Med
(2000) - et al.
Treatment of acute otitis media with an antiadhesive oligosaccharide: A randomised, double-blind, placebo-controlled trial
Lancet
(2000) Unbiased, relevant, and reliable assessments in health care: Important progress during the past century, but plenty of scope for doing better
BMJ
(1998)Patient recruitment—European perspective
Pediatrics
(1999)
Survey of unlicensed and off label drug use in paediatric wards in European countries
BMJ
(2000)
(2002)
Database could give children safer medicines
Nature
(2000)
Science's neglected legacy
Nature
(2000)
Abstracts of randomized controlled trials presented at the Society for Pediatric Research meeting: An example of publication bias
Register of clinical trials in children must be set up
BMJ
(2000)
Research with children. Paediatric practice needs better evidence—gained in collaboration with parents and children
BMJ
(2001)
Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids
Am J Respir Crit Care Med
(1995)
Salmeterol xinafoate in children on high dose inhaled steroids
Ann Allergy Asthma Immunol
(1995)
Salmeterol (50 mcg b.i.d.) versus nedocromil (4 mg t.i.d.): Protective effect against hyperreactivity to ultrasonically nebulised distilled water in asthmatic children
Riv Ital Pediatr
(1995)
Effect of a month of treatment with inhaled steroids (flunisolide) on the bronchial responsiveness in children with moderate asthma
Riv Ital Pediatr
(1995)
Efficacy of a new non-ozone depleting formulation for salbutamol
J Pharmacol Med
(1995)
Cited by (17)
Guanfacine for attention deficit and hyperactivity disorder in pediatrics: A systematic review and meta-analysis
2014, European NeuropsychopharmacologyCitation Excerpt :From this point of view, a risk of an unnecessary drug experimentation in the pediatric population seems to exist, raising ethical concerns.( Clavenna et al., 2002) Scientific community and regulatory agencies should make every effort to reduce unnecessary replication of trials, in particular in vulnerable populations.( Chalmers et al., 2014; European Commission, 2008) Moreover, the lack of comparative studies may reflect the interests of the market rather than those of patients and health service. (
Do children really need more research on respiratory drugs?
2010, Acta Paediatrica, International Journal of PaediatricsDrug prescriptions in children and the elderly in the Lombardy Region
2010, Ricerca e PraticaChildren's presence in research. a review of online registers
2009, European Journal of Clinical PharmacologyRegistration of trials in children: Update of current international initiatives
2009, Archives of Disease in Childhood
Copyright © 2002 Published by Elsevier Inc.